Evidence Library
Filter by drug, type, year, and open access.
Showing 1–4 of 4 results
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults — Canadian Journal of Psychiatry (2024)• Drug: olanzapine-fluoxetineDOIPMID
- APA Clinical Practice Guideline for the Treatment of Depression — American Psychiatric Association (2023)• Drug: olanzapine-fluoxetineOpen access
- The CANMAT and ISBD Guidelines for the Management of Patients With Bipolar Disorder: 2021 Update — Bipolar Disorders (2021)• Drug: olanzapine-fluoxetineDOI
- Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression — Archives of General Psychiatry (2003)• Drug: olanzapine-fluoxetinePMID